Followers | 6 |
Posts | 283 |
Boards Moderated | 0 |
Alias Born | 06/16/2021 |
Monday, October 25, 2021 10:07:38 AM
For those hoping that Intel/Samsung Biologics will buy in, that introduces a possible problem: Giving up some level of control.
If $ENZC reinvents the business model for bringing drugs/cures to market (without having to go through big pharma), the less outside influence, the better.
I feel that $ENZC is at the point where Facebook was when Zuckerberg figured out that his company was worth more to keep and develop on his own going forward than it was to sell out. That decision has paid off handsomely.
Go $ENZC!
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM